Apr 9, 2025 | Blog, Blood Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
A phase 1 trial of a novel cell therapy for lymphoma that is highly resistant to standard treatment (highly refractory lymphoma) has published very positive results in the Nature Medicine journal. The therapy, which uses natural killer (NK) cells derived from cord...
Mar 27, 2025 | Blog, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Tissue
Getting older is not just about grey hair and wrinkles. The body can deteriorate, losing muscle tone and strength, making daily life activities more difficult and tiring. What’s more, the immune system also weakens, making older adults more likely to get sick and less...
Mar 22, 2025 | Blog, News, Skeletal Diseases and Injuries, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
Osteoarthritis, a chronic degenerative joint disease, affects millions of people worldwide and is a leading cause of disability.[1][2] Currently available treatments can offer relief from pain and other symptoms. However, they fail to address the root of the disease,...
Mar 7, 2025 | Blog, Neurological Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood, Uses for Cord Tissue
A new study on cell therapy for cerebral palsy has, for the first time, directly compared the efficacy of two different treatments. Although more research is needed, the study’s results offer valuable insights for future clinical trials tackling this challenging...
Feb 20, 2025 | Blog, News, Uses for Placenta
After an acid attack that “melted” his left eye, Paul Laskey thought he would lose his sight entirely. Now, a series of amnion grafts from a donated placenta has saved his eye, stabilising it and preventing further damage.[1] A long road to recovery Mr Laskey, from...
Feb 17, 2025 | Blog, Blood Disorders, News, Stem Cell News, Stem Cell Therapies, Uses for Cord Blood
A CAR-T cell therapy for acute lymphoblastic leukaemia[1] has recently been approved by the FDA for use in clinical trials in the United States. The therapy is based on cells derived from allogeneic (donor) umbilical cord blood; it is the very first such treatment to...